A 32-year-old woman on antiretroviral therapy is initiated on tuberculosis preventive therapy under NTEP. Which short-course rifapentine-based regimen is currently recommended for people living with HIV?
- A Isoniazid daily for 36 months as secondary prophylaxis
- B Rifampicin plus isoniazid daily for 3 months
- C Rifapentine daily for 1 month alongside pyridoxine
- D Rifapentine plus isoniazid weekly for 12 weeks ✓
Explanation
The 3HP regimen, weekly rifapentine plus isoniazid for a total of 12 doses over 12 weeks, is the short-course TPT option recommended for people living with HIV under NTEP guidance, with efficacy comparable to 6 months of isoniazid and better completion rates. Option C describes the 1HP regimen used in some settings but is not the standard Indian recommendation here. Option A is not an accepted TPT schedule. Rifapentine must never be combined with protease inhibitors without adjustment.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.